Knight Therapeutics | GUD - Ativos





Ativos Alterar Data
Acasti Pharma USD 66.58M 3.22M 2025-09
Akebia Therapeutics USD 362.52M 14.04M 2026-03
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Aurora Cannabis CAD 775.29M 18.43M 2025-12
Avita Medical AUD 56.39M 1.74M 2025-12
Canopy Growth CAD 1.11B 36.35M 2025-12
Cronos Group USD 1.17B 25.03M 2026-03
Dianthus Therapeutics USD 1.25B 715.96M 2026-03
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
IQVIA Holdings USD 29.68B 269M 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Moderna USD 11.49B 850M 2026-03
Omeros USD 200.57M 34.59M 2025-06
Organigram Holdings CAD 530.67M 31.54M 2025-12
Organon & Co USD 13B 129M 2026-03
Revvity USD 12B 171.82M 2026-03
Tectonic Therapeutic USD 246.58M 14.46M 2026-03
Tilray USD 2.1B 15.95M 2025-09
Viatris USD 36.83B 358.5M 2026-03
Xeris Pharmaceuticals USD 392.01M 8.49M 2026-03